News
-
Renflexis approval
Monday | Dec 19 2016THE Generic and Biosimilar Medicines Association (GBMA) has welcomed a positive PBAC recommendation for PBS listing of Renflexis, an infliximab biosimilar.
-
Asthma approvals
Monday | Dec 19 2016HEALTH minister Sussan Ley yesterday confirmed the government would invest close to $130 million to give people with severe uncontrolled asthma access to "breakthrough medicines" via the Pharmaceutical Benefits Scheme (PBS).
-
Pregnancy update
Monday | Dec 19 2016THE Therapeutic Goods Administration has updated its Prescribing Medicines in Pregnancy Database, with the addition of six recently registered medicines including albutrepenonacog alfa (cat B2), dapagliflozin/saxagliptin (cat D), fomepizole (cat B2), paritaprevir/ritonavir/ombitasvir (cat B3), paritaprevir/ritonavir/ombitasvir with ribavirin (cat X) and technetium albumin aggregated (cat C) - for details see tga.gov.au.
-
Nurofen fine upped to $6m
Monday | Dec 19 2016THE Full Federal Court has upheld an appeal by the Australian Competition and Consumer Commission (ACCC) which had filed a Notice of Appeal against the $1.7 million fine imposed upon Reckitt Benckiser (RB) for contravening Australian Consumer Law (PD 24 May 16).
-
Review Panel interim report in Feb
Monday | Dec 19 2016THE Panel conducting the government's Review of Pharmacy Remuneration and Regulation has confirmed it will release its Interim Report in Feb 2017, "to allow everyone equal time and opportunity to consider and provide new feedback and comments".
-
Sydney to offer CM course
Monday | Dec 19 2016THE Faculty of Pharmacy at the University of Sydney has announced the debut of a new Graduate Certificate in Evidence-Based Complementary Medicines.
-
-
Dispensary Corner 16 Dec 16
Friday | Dec 16 2016PARENTS and anti-drug advocates are up in arms over a pair of toddler-sized leggings for sale on Amazon Fashion which appear to have marijuana leaves printed all over them.
-
FDA ticks Eucrisa
Friday | Dec 16 2016THE US Food and Drug Administration (FDA) has approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
-
PSS volunteer call
Friday | Dec 16 2016THE Pharmacists' Support Service (PSS) is calling for volunteers to be on duty from 8 am to 11 pm each day for at least two weeks per year depending on availability.
